arvind gupta

Disrupt 2022’s climate tech and health tech sessions

Between the climate crisis and global pandemics, we’re living in remarkably fraught times. Undaunted by the magnitude of the challenges, Silicon Valley has been hard at work seeking to mitigate the

Cultured meat startup Prolific Machines unveils its ‘Henry Ford approach’ to cell growth

Its technology is a way to grow and control cells without the need for any of those expensive recombinant proteins for cell production.

Check out the official Disrupt 2022 roundtables

I tell you what, folks. The roundtable discussions at TechCrunch Disrupt — coming to you live and in person on October 18-20 in San Francisco — will be off the hook. Disrupt attendees love roundta

How to pitch me: 6 investors discuss what they’re looking for in April 2022

Smaller seed rounds mean shorter runways, so partnering with an investor who actually understands your business well enough to add value is critical.

Daily Crunch: Beating ‘other takeover bidders,’ Bosch acquires autonomous driving startup Five.ai

Hello friends and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.

TechCrunch+ roundup: The Kindbody TC-1, Glossier’s mistakes, calculating startup runway

With a focus on education that addresses the fragmentation associated with infertility care, Kindbody is growing at a remarkable pace, but it's also helping many patients feel seen and heard for the f

Daily Crunch: FDA clears Fitbit algorithm that passively scans for signs of AFib

Hello friends and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.

Mayfield’s Arvind Gupta discusses startup fundraising during a downturn

"It's important as an investor to be extremely humble, because we're going to be wrong a lot. I have this phrase that I use all the time: knowledge competes with imagination."

TechCrunch+ roundup: ‘Valuation reset,’ spiking crypto losses, US insurtech meltdown

Has it ever been your responsibility to tell someone else that their job has been eliminated? I have, and it's one of the most difficult things I've ever done at work.

How to pitch me: 4 VCs share what they’re looking for in March 2022

To learn more about where top VCs are searching for opportunities, and solicit their advice for entrepreneurs who want to attract attention, I asked four investors to share their thoughts.

Key takeaways from the SOSV Climate Tech Summit

Two weeks ago, 50 founders and investors shared their insights on how the world can tackle the planetary "Code Red" with over 2,000 participants at the inaugural SOSV Climate Tech Summit.

SOSV’s burgeoning climate portfolio is worth nearly $6 billion as planetary health bets pay off

The burgeoning climate-focused portfolio from early-stage investor SOSV Investments has managed to raise nearly $2 billion in follow-on financing since the startup companies graduated from the investm

Early-stage investor Mayfield shows how to scale up your biotech startup at TC Early Stage in April

Founders in the earliest stages of startup life face a hefty learning curve. Just some of the core competencies you need to lock down include how to raise VC funding, recruiting the right people, find

Synthetic biology startups are giving investors an appetite

There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies. Perhaps the most public (and tastiest) example of the promi

Leaving the $3.2 billion portfolio he helped build at IndieBio, Arvind Gupta joins Mayfield to create the Genesis Consortium

Arvind Gupta, the founder and head of IndieBio, is leaving the accelerator whose portfolio he helped build into a $3.2 billion life sciences powerhouse, to join the venture capital fund Mayfield. The

Where top VCs are investing in healthcare B2B and infrastructure

Rising healthcare costs, an aging population, stifling regulations and the complexity of present-day technological offerings make the trillion-dollar healthcare industry ripe for disruption. Not only

Startups Weekly: Upfront Ventures bets on a bus service

In this week's newsletter: Airbnb, WeWork and Postmates prep IPOs.

At TechCrunch Disrupt, insights into key trends in venture capital

Learn from top VCs at TechCrunch Disrupt.

Mushroom leather, tiny Zika detectors and lab-made breast milk debut at IndieBio’s third demo day

The accelerator’s demo day has grown so big we’re now live streaming it on TechCrunch. But it was just a couple years ago that the only pure biotech accelerator launched out of SOS Venture